Parkinson's Disease Trial, Recruiting NCT06133283 Sponsor: The University of Texas Health Science Center at San Antonio Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Recruiting

NCT06133283
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 85 who have been diagnosed with idiopathic Parkinson's disease (Parkinson's that developed without a known cause) at a mid-range stage of the condition (Hoehn and Yahr stages 2–3).
  • People who score 23 or higher on a standard memory and thinking test called the Mini Mental State Examination, indicating a certain level of cognitive ability.
  • People who score 21.5 or below on a balance assessment called the Mini Balance Evaluation Systems Test (miniBESTest), indicating some difficulty with balance.

Who may not be able to join:

  • People who have a history of other neurological conditions, such as stroke or multiple sclerosis.
  • People who have a history of serious heart or lung disease, uncontrolled high blood pressure, a sudden drop in blood pressure when standing, uncontrolled diabetes, severe bone thinning (osteoporosis), or severe arthritis affecting the joints of the lower body.
  • People who have previously had surgery related to their Parkinson's disease, such as deep brain stimulation.
  • People who have a history of a significant head injury.
  • People who have a history of seizures or epilepsy.
  • People who are currently pregnant.
  • People who take medications that could affect brain activity or increase the risk of having a seizure.
  • People who have abnormalities or fractures in their skull, or who experience unexplained, recurring headaches.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Anjali Sivaramakrishnan, The University of Texas Health Science Center at San Antonio

Phone: 210-567-8626

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The University of Texas Health Science Center at San Antonio
Registry
ClinicalTrials.gov
Start date
9 February 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Balance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov